Advertisement

best practice onkologie

, Volume 6, Issue 4, pp 27–27 | Cite as

JAK-Inhibitor Ruxolitinib als zukünftige neue Behandlungsoption?

Panorama Myelofibrose
  • 32 Downloads

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Personalised recommendations